首页> 外文会议>International Forum on Progress on Post-Genome Technologies(5'IFPT); 20070910-11; Suzhou(CN) >Hepatitis C Virus Genotyping and Serum Anti-F Antibody Detection of HCV Patients in the South of Jiangsu Province of China
【24h】

Hepatitis C Virus Genotyping and Serum Anti-F Antibody Detection of HCV Patients in the South of Jiangsu Province of China

机译:苏南地区丙型肝炎患者丙型肝炎病毒基因分型和血清抗F抗体检测

获取原文
获取原文并翻译 | 示例

摘要

This study investigated the distribution of hepatitis C virus (HCV) genotypes and assessed the prevalence and distribution of serum anti-F in patients with hepatitis C virus (HCV) infection in the south of Jiangsu province of China. One hundred and fifty-eight anti-HCV positive sera samples were indentified by the PCR with type specific primers designed according to the sequence of 5’-non-coding region (5’ NCR). Indirect ELISA was carried to detect anti-F in sera of 120 HCV patients and 10 donors. Ninty-five HCV RNA positive patients (95/158) were classified as 80 (80/95, 84.2%) genotype 1b, 5 (5/95, 5.3%) genotype 2, 5 (5/95, 5.3%) genotype 1b/2 mixed and 5 (5/95, 5.3%) genotype undetermined. Then genotype 1b was the predominant in the south of jiangsu province of China. The difference on the distribution of HCV genotypes was significant between female and male patients(p<0.05), but not in different kinds of HCV patients. Eighty-two samples (68%) out of the 120 HCV infected patients exhibited a positive anti-F reaction, showing significant difference from the controls without HCV infection (p<0.01). Chi-square test showed that there were no significant correlations between anti-F antibody and sex, HCV RNA serum , types of HCV RNA. Patients of midrange, severe range and hepatic cirrhosis have higher rate than others(p<0.05), the positive rate of anti-F is higher in patients over fifties(p<0.01). This report of the serum anti-F prevalence and distribution of anti-F in the South of Jiangsu Province hepatitis C patients may help the investigation of the pathogenesis of HCV, and functions of F protein.
机译:这项研究调查了丙型肝炎病毒(HCV)基因型的分布,并评估了江苏省南部丙型肝炎病毒(HCV)感染患者血清抗F的患病率和分布。通过PCR鉴定了158个抗HCV阳性血清样品,并根据5'非编码区(5'NCR)的序列设计了类型特异性引物。进行间接ELISA检测120例HCV患者和10个供体的血清中抗F。九十五位HCV RNA阳性患者(95/158)被分类为80基因型(80/95,84.2%)1b,5基因型(5/95,5.3%)2,5(5/95,5.3%)基因型1b / 2混合和5(5/95,5.3%)基因型未定。然后基因型1b在中国江苏省南部占主导地位。男女患者HCV基因型分布差异显着(p <0.05),但不同类型的HCV患者差异无统计学意义。在120例被HCV感染的患者中,有82个样品(68%)显示出抗F反应阳性,与未感染HCV的对照组相比有显着差异(p <0.01)。卡方检验显示抗F抗体与性别,HCV RNA血清,HCV RNA类型之间无显着相关性。中重度,重度肝硬化患者的发生率高于其他人群(p <0.05),五十多岁的患者抗-F阳性率较高(p <0.01)。这份关于苏南丙型肝炎患者血清抗F发生率和抗F分布的报告可能有助于调查HCV的发病机理和F蛋白的功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号